TEK and cancer: Moreover, epithin/PRSS14 can proteolytically activate growth factors/receptors, including protease-activated receptor 2 [39, 40], hepatocyte growth factor [17], and Tie2 [13], and thus modulate extracellular environments favoring the migration and invasion of cancer or immune cells.